Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
POINT Biopharma Global Inc. | EVP Clinical Development | Stock Option (Right to Buy) | 0 | Dec 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PNT | POINT Biopharma Global Inc. | Dec 27, 2023 | 5 | $0 | 4 | Dec 27, 2023 | EVP Clinical Development |
PNT | POINT Biopharma Global Inc. | Mar 28, 2023 | 1 | $0 | 4 | Mar 30, 2023 | EVP Clinical Development |
PNT | POINT Biopharma Global Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | EVP Clinical Development |
PNT | POINT Biopharma Global Inc. | Mar 29, 2022 | 1 | $0 | 4 | Mar 31, 2022 | EVP Clinical Development |
PNT | POINT Biopharma Global Inc. | Jul 6, 2021 | 1 | $0 | 4 | Jul 8, 2021 | EVP Clinical Development |
PNT | POINT Biopharma Global Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jun 30, 2021 | EVP Clinical Development |
PNT | POINT Biopharma Global Inc. | Jun 30, 2021 | 0 | $0 | 3 | Jun 30, 2021 | EVP Clinical Development |